Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Rob Evans & Kamlaj Sayal. (2012) Gammabutyrolactone: withdrawal syndrome resembling delirium tremens. Journal of Substance Use 17:4, pages 384-387.
Read now
Read now
Leo J Schep, Kai Knudsen, Robin J Slaughter, J Allister Vale & Bruno Mégarbane. (2012) The clinical toxicology of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol. Clinical Toxicology 50:6, pages 458-470.
Read now
Read now
W.
R. Murray Bennett, LawrenceG. Wilson & PeterP. Roy-Byrne. (2007) Gamma-Hydroxybutyric Acid (GHB) Withdrawal: A Case Report. Journal of Psychoactive Drugs 39:3, pages 293-296.
Read now
Read now
RobertS. Gable. (2004) Acute Toxic Effects of Club Drugs. Journal of Psychoactive Drugs 36:3, pages 303-313.
Read now
Read now
Alvaro Camacho, Scott C. Matthews & Joel E. Dimsdale. (2004) Use of GHB Compounds by HIV-Positive Individuals. American Journal on Addictions 13:2, pages 120-127.
Read now
Read now
. (2003) The Abrupt Cessation of Therapeutically Administered Sodium Oxybate (GHB) Does Not Cause Withdrawal Symptoms. Journal of Toxicology: Clinical Toxicology 41:2, pages 131-135.
Read now
Read now
Mark H. Rosenberg$suffix/text()$suffix/text(), Laurie J. Deerfield$suffix/text()$suffix/text() & Edward M. Baruch$suffix/text()$suffix/text(). (2003) Two Cases of Severe Gamma-Hydroxybutyrate Withdrawal Delirium on a Psychiatric Unit: Recommendations for Management. The American Journal of Drug and Alcohol Abuse 29:2, pages 487-496.
Read now
Read now
CharlesH. McDaniel & KarenA. Miotto. (2001) Gamma Hydroxybutyrate (GHB) and Gamma Butyrolactone (GBL) Withdrawal: Five Case Studies. Journal of Psychoactive Drugs 33:2, pages 143-149.
Read now
Read now
P. Dillon & L. Degenhardt. (2001) Ketamine and GHB: new trends in club drug use?. Journal of Substance Use 6:1, pages 11-15.
Read now
Read now
MichaelP. Bogenschutz. (2000) Drug Information Libraries on the Internet. Journal of Psychoactive Drugs 32:3, pages 249-258.
Read now
Read now
Articles from other publishers (36)
Guillaume Drevin, Marie Briet, Severine Ferec, Julien Demiselle, François Beloncle & Chadi Abbara. (2023) Acute Sodium Oxybate Intoxication: A Case Report and Review of the Literature. Therapeutic Drug Monitoring 45:2, pages 277-281.
Crossref
Crossref
Icro Maremmani, Matteo Pacini & Angelo G. I. MaremmaniIcro Maremmani, Matteo Pacini & Angelo G. I. Maremmani. 2023. Dual Disorder Heroin Addicts. Dual Disorder Heroin Addicts
183
195
.
R. Andrew Yockey, Keith King & Rebecca Vidourek. (2021) Trends in Suicidal Behaviors Among US Adults 2015–2018. Crisis 42:5, pages 351-359.
Crossref
Crossref
Enrico Marinelli, Renata Beck, Antonio Malvasi, Alfredo Fabrizio Lo Faro & Simona Zaami. (2020) Gamma-hydroxybutyrate abuse: pharmacology and poisoning and withdrawal management. Archives of Industrial Hygiene and Toxicology 71:1, pages 19-26.
Crossref
Crossref
Patrick J. Buckley & Chelsea T. Wolf. (2018) Psychosis in a 22-Year-Old Woman With Narcolepsy After Restarting Sodium Oxybate. Psychosomatics 59:3, pages 298-301.
Crossref
Crossref
Louis von Theobald, Morgane Rousselet, Jennyfer Cholet, Hélène Debar, David Boels, Caroline Victorri-Vigneau & Marie Grall-Bronnec. (2017) Inpatient Gamma-Hydroxybutyrate Detoxification: A Case Report Describing Day-to-day Therapeutic Management. Journal of Addiction Medicine 11:3, pages 231-234.
Crossref
Crossref
Rama M. Kamal, Martijn S. van Noorden, Wim Wannet, Harmen Beurmanjer, Boukje A. G. Dijkstra & Arnt Schellekens. (2016) Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention. CNS Drugs 31:1, pages 51-64.
Crossref
Crossref
J.G.C. van Amsterdam, T.M. Brunt, M.T.B. McMaster & W. van den Brink. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
453
459
.
Joseph ChienGina OstermannSusan Beckwitt Turkel. (2013) Sodium Oxybate-Induced Psychosis and Suicide Attempt in an 18-Year-Old Girl. Journal of Child and Adolescent Psychopharmacology 23:4, pages 300-301.
Crossref
Crossref
Pasarapa Towiwat, Siripan Phattanarudee & Timothy J. Maher. (2013) Comparative study of equimolar doses of gamma-hydroxybutyrate (GHB), 1,4-butanediol (1,4-BD) and gamma-butyrolactone (GBL) on catalepsy after acute and chronic administration. Food and Chemical Toxicology 51, pages 337-342.
Crossref
Crossref
Jan G.C. van Amsterdam, Tibor M. Brunt, Minni T.B. McMaster & Raymond J.M. Niesink. (2012) Possible long-term effects of γ-hydroxybutyric acid (GHB) due to neurotoxicity and overdose. Neuroscience & Biobehavioral Reviews 36:4, pages 1217-1227.
Crossref
Crossref
Laurent Karila, Johanne Novarin, Bruno Megarbane, Olivier Cottencin, Sylvain Dally, William Lowenstein & Michel Reynaud. (2009) Acide gamma-hydroxy-butyrique (GHB) : plus qu’un agent de soumission chimique, une véritable source d’addiction. La Presse Médicale 38:10, pages 1526-1538.
Crossref
Crossref
Florian D. Zepf, Martin Holtmann, Eftichia Duketis, Joachim Maier, Daniel Radeloff, Shella Schirman, Angela Wagner, Fritz Poustka & Lars Wöckel. (2009) Entzugsdelir nach Missbrauch von GHB-(Gamma-Hydroxybutyrat) und seiner Vorstufen. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 37:5, pages 413-420.
Crossref
Crossref
Lawrence P. Carter, Wouter Koek & Charles P. France. (2009) Behavioral analyses of GHB: Receptor mechanisms. Pharmacology & Therapeutics 121:1, pages 100-114.
Crossref
Crossref
Jeremy M. Wojtowicz, Mark C. Yarema & Paul M. Wax. (2015) Withdrawal from gamma-hydroxybutyrate, 1,4-butanediol and gamma-butyrolactone: a case report and systematic review. CJEM 10:01, pages 69-74.
Crossref
Crossref
LAWRENCE S. QUANG. 2007. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose
803
823
.
L. S QUANG, G. COLOMBO, C. LOBINA, P. MACCIONI, A. ORRU`, G. L. GESSA, T. J MAHER & M. A.M CARAI. (2006) Evaluation for the Withdrawal Syndrome from -Hydroxybutyric Acid (GHB), -Butyrolactone (GBL), and 1,4-Butanediol (1,4-BD) in Different Rat Lines. Annals of the New York Academy of Sciences 1074:1, pages 545-558.
Crossref
Crossref
S BALACHANDRA DASS & SYED F. ALI. (2004) Evaluation of γ-Hydroxybutyric Acid for Genotoxicity in the Mouse Micronucleus Assay. Annals of the New York Academy of Sciences 1025:1, pages 538-542.
Crossref
Crossref
Linda Metzner, Jutta Kalbitz & Matthias Brandsch. (2004) Transport of Pharmacologically Active Proline Derivatives by the Human Proton-Coupled Amino Acid Transporter hPAT1. Journal of Pharmacology and Experimental Therapeutics 309:1, pages 28-35.
Crossref
Crossref
Theodore C. Bania, Tom Ashar, Gregory Press & Patricia M. Carey. (2008) Gamma‐hydroxybutyric Acid Tolerance and Withdrawal in a Rat Model. Academic Emergency Medicine 10:7, pages 697-704.
Crossref
Crossref
Laura G. Hensley. (2011) Drug‐Facilitated Sexual Assault on Campus: Challenges and Interventions. Journal of College Counseling 5:2, pages 175-181.
Crossref
Crossref
Phillip E. Mason & William P. KernsIIII. (2008) Gamma Hydroxybutyric Acid (GHB) Intoxication. Academic Emergency Medicine 9:7, pages 730-739.
Crossref
Crossref
YOSSEF ITZHAK & SYED F. ALI. (2006) Repeated Administration of Gamma-Hydroxybutyric Acid (GHB) to Mice. Annals of the New York Academy of Sciences 965:1, pages 451-460.
Crossref
Crossref
Philip A Bialer. (2002) Designer drugs in the general hospital. Psychiatric Clinics of North America 25:1, pages 231-243.
Crossref
Crossref
Karen Miotto, Jack Darakjian, Janice Basch, Shanna Murray, Jennifer Zogg & Richard Rawson. (2010) Gamma‐Hydroxybutyric Acid: Patterns of Use, Effects and Withdrawal. The American Journal on Addictions 10:3, pages 232-241.
Crossref
Crossref
Aaron B Schneir, Binh T Ly & Richard F Clark. (2001) A case of withdrawal from the GHB precursors gamma-butyrolactone and 1,4-butanediol. The Journal of Emergency Medicine 21:1, pages 31-33.
Crossref
Crossref
C. Jones. (2001) Suspicious death related to gamma-hydroxybutyrate (GHB) toxicity. Journal of Clinical Forensic Medicine 8:2, pages 74-76.
Crossref
Crossref
Katherine L. Nicholson & Robert L. Balster. (2001) GHB: a new and novel drug of abuse. Drug and Alcohol Dependence 63:1, pages 1-22.
Crossref
Crossref
Toya M. Bowles, Roger W. Sommi & Mohsen Amiri. (2012) Successful Management of Prolonged γ‐Hydroxybutyrate and Alcohol Withdrawal. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 21:2, pages 254-257.
Crossref
Crossref
Maria C. Catalano, Jillian M. Glass, Glenn Catalano, Stephanie L. Burrows, William A. Lynn & Bradley S. Weitzner. (2001) Gamma Butyrolactone (GBL) Withdrawal Syndromes. Psychosomatics 42:1, pages 83-88.
Crossref
Crossref
MICHAEL SHANNON & LAWRENCE S. QUANG. (2000) Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol: A case report and review of the literature. Pediatric Emergency Care 16:6, pages 435-440.
Crossref
Crossref
S. R. Araneo, E. Cesarotti & D. Berta. (2000) Kinetic resolution of chiral racemic alcohols by BITIANP-ruthenium(II)-catalysed hydrogenation. Applied Organometallic Chemistry 14:11, pages 735-738.
Crossref
Crossref
Giancarlo Colombo & Gian Luigi Gessa. (2006) Gamma‐hydroxybutyric acid in alcohol preference, dependence and withdrawal. Addiction Biology 5:4, pages 389-403.
Crossref
Crossref
Meite S. Moser & Roy A. Purssell. (2015) Gamma-hydroxybutyrate overdose and coma: a case report. CJEM 2:03, pages 203-205.
Crossref
Crossref
Jasdeep S Miglani, Kye Y Kim & Ritu Chahil. (2000) Gamma-hydroxy butyrate withdrawal delirium: a case report. General Hospital Psychiatry 22:3, pages 213-215.
Crossref
Crossref
Kathryn Craig, Hernan F Gomez, John L McManus & Theodore C Bania. (2000) Severe gamma-hydroxybutyrate withdrawal: a case report and literature review. The Journal of Emergency Medicine 18:1, pages 65-70.
Crossref
Crossref